PIPA5102738

GHRH Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5102738-Each-of-1 In Stock ₹ 45,968.50

PIPA5102738 - Each of 1

₹ 45,968.50

In Stock

Quantity

1

Base Price: ₹ 45,968.50

GST (18%): ₹ 8,274.33

Total Price: ₹ 54,242.83

Antigen

GHRH

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Ghrh

Gene Alias

GHRF; Ghrh; GRF; growth hormone releasing hormone; growth hormone-releasing factor; Growth hormone-releasing hormone; INN; MGC119781; OTTHUMP00000030915; Sermorelin; somatocrinin; Somatoliberin; somatorelin

Host Species

Rabbit

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

14601, 2691, 29446

Content And Storage

-20°C

Form

Liquid

Applications

Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot

Concentration

1 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide; pH 7.4

Gene Accession No.

P01286, P09916, P16043

Gene Symbols

Ghrh

Immunogen

A synthesized peptide derived from human GHRH(Accession P01286), corresponding to amino acid residues N39-M89.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA5106355

--

Img

Thermo Scientific

PIPA5100661

--

Img

Thermo Scientific

PIPA5102461

--

Img

Thermo Scientific

PIPA5102652

--

Img

Thermo Scientific

PIPA5100817

--

Img

Thermo Scientific

PIPA5115210

--

Img

Thermo Scientific

PIPA5115234

--

Img

Thermo Scientific

PIPA5101617

--

Description

  • Antibody detects endogenous levels of total GHRH
  • The activated kinase acts on a variety of targets
  • Likely to be the GTPase effector that links the Rho-related GTPases to the JNK MAP kinase pathway
  • Activated by CDC42 and RAC1
  • Involved in dissolution of stress fibers and reorganization of focal complexes
  • Involved in regulation of microtubule biogenesis through phosphorylation of TBCB
  • Activity is inhibited in cells undergoing apoptosis, potentially due to binding of CDC2L1 and CDC2L2.